Fidson Healthcare Plc (NGX:FIDSON)
Nigeria
· Delayed Price · Currency is NGN 88.50
+6.00 (7.27%)
At close: Mar 6, 2026
Fidson Healthcare Income Statement
Financials in millions NGN. Fiscal year is January - December.
Millions NGN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 119,061 | 84,189 | 53,050 | 40,634 | 30,861 | Upgrade
|
| Revenue Growth (YoY) | 41.42% | 58.70% | 30.56% | 31.67% | 68.86% | Upgrade
|
| Cost of Revenue | 70,837 | 49,731 | 32,260 | 23,667 | 16,061 | Upgrade
|
| Gross Profit | 48,224 | 34,458 | 20,790 | 16,967 | 14,800 | Upgrade
|
| Selling, General & Admin | 22,604 | 16,186 | 11,802 | 9,583 | 9,534 | Upgrade
|
| Other Operating Expenses | -884.28 | -610.97 | -488.78 | -783.26 | -513.29 | Upgrade
|
| Operating Expenses | 21,896 | 15,876 | 11,541 | 8,754 | 9,021 | Upgrade
|
| Operating Income | 26,328 | 18,582 | 9,249 | 8,213 | 5,779 | Upgrade
|
| Interest Expense | -7,101 | -5,494 | -2,102 | -1,773 | -1,222 | Upgrade
|
| Interest & Investment Income | 144.32 | 60.02 | 23.01 | 65.42 | 77.72 | Upgrade
|
| Currency Exchange Gain (Loss) | -5,510 | -5,449 | -1,261 | -758.6 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | 13,861 | 7,700 | 5,909 | 5,747 | 4,634 | Upgrade
|
| Gain (Loss) on Sale of Assets | 31.31 | 0.91 | 8.29 | 34.23 | 83.26 | Upgrade
|
| Pretax Income | 13,892 | 7,700 | 5,917 | 5,781 | 4,718 | Upgrade
|
| Income Tax Expense | 4,584 | 1,921 | 2,310 | 1,594 | 997.73 | Upgrade
|
| Net Income | 9,308 | 5,779 | 3,608 | 4,187 | 3,720 | Upgrade
|
| Net Income to Common | 9,308 | 5,779 | 3,608 | 4,187 | 3,720 | Upgrade
|
| Net Income Growth | 61.05% | 60.20% | -13.84% | 12.56% | 208.70% | Upgrade
|
| Shares Outstanding (Basic) | 2,399 | 2,295 | 2,295 | 2,295 | 2,295 | Upgrade
|
| Shares Outstanding (Diluted) | 2,399 | 2,295 | 2,295 | 2,295 | 2,295 | Upgrade
|
| Shares Change (YoY) | 4.53% | - | - | - | - | Upgrade
|
| EPS (Basic) | 3.88 | 2.52 | 1.57 | 1.82 | 1.62 | Upgrade
|
| EPS (Diluted) | 3.88 | 2.52 | 1.57 | 1.82 | 1.62 | Upgrade
|
| EPS Growth | 54.07% | 60.20% | -13.84% | 12.56% | 208.70% | Upgrade
|
| Free Cash Flow | 5,608 | -4,198 | -2,898 | -2,873 | 2,234 | Upgrade
|
| Free Cash Flow Per Share | 2.34 | -1.83 | -1.26 | -1.25 | 0.97 | Upgrade
|
| Dividend Per Share | - | 1.000 | 0.600 | 0.550 | 0.455 | Upgrade
|
| Dividend Growth | - | 66.67% | 9.09% | 21.01% | 99.96% | Upgrade
|
| Gross Margin | 40.50% | 40.93% | 39.19% | 41.76% | 47.96% | Upgrade
|
| Operating Margin | 22.11% | 22.07% | 17.44% | 20.21% | 18.73% | Upgrade
|
| Profit Margin | 7.82% | 6.87% | 6.80% | 10.30% | 12.05% | Upgrade
|
| Free Cash Flow Margin | 4.71% | -4.99% | -5.46% | -7.07% | 7.24% | Upgrade
|
| EBITDA | 28,567 | 20,215 | 10,458 | 9,110 | 6,474 | Upgrade
|
| EBITDA Margin | 23.99% | 24.01% | 19.71% | 22.42% | 20.98% | Upgrade
|
| D&A For EBITDA | 2,239 | 1,632 | 1,209 | 897.42 | 695.39 | Upgrade
|
| EBIT | 26,328 | 18,582 | 9,249 | 8,213 | 5,779 | Upgrade
|
| EBIT Margin | 22.11% | 22.07% | 17.44% | 20.21% | 18.73% | Upgrade
|
| Effective Tax Rate | 33.00% | 24.95% | 39.03% | 27.58% | 21.15% | Upgrade
|
| Advertising Expenses | 1,424 | 626.93 | 1,183 | 1,400 | 663.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.